Clinical Rheumatology

Article	Citations
Autoimmune post-COVID vaccine syndromes: does the spectrum of autoimmune/inflammatory syndrome expand?	91
COVID-19 and the clinical course of rheumatic manifestations	88
Long COVID: rheumatologic/musculoskeletal symptoms in hospitalized COVID-19 survivors at 3 and 6 months	82
Post-COVID-19 arthritis: a case report and literature review	75
Ankylosing spondylitis risk factors: a systematic literature review	62
Haemophagocytic syndrome and COVID-19	58
Disease-modifying anti-rheumatic drugs for the management of Takayasu arteritis—a systematic review and meta-analysis	56
Expanding spectrum of DADA2: a review of phenotypes, genetics, pathogenesis and treatment	52
Long COVID from rheumatology perspective — a narrative review	50
Incident autoimmune diseases in association with SARS-CoV-2 infection: a matched cohort study	46
Long-term glucocorticoid treatment and high relapse rate remain unresolved issues in the real-life management of polymyalgia rheumatica: a systematic literature review and meta-analysis	44
Systemic inflammation response index (SIRI) as a novel biomarker in patients with rheumatoid arthritis: a multi-center retrospective study	43
COVID-19 vaccination in immunocompromised patients	42
Side effects and flares risk after SARS-CoV-2 vaccination in patients with systemic lupus erythematosus	37
Diagnostic delay in axial spondyloarthritis: a systematic review	37
Clinical features and outcome of MIS-C patients: an experience from Central Anatolia	34
Machine learning to identify immune-related biomarkers of rheumatoid arthritis based on WGCNA network	34
Clinical features and outcomes of 76 patients with COVID-19-related multi-system inflammatory syndrome in children	34
Dorsal root ganglia: fibromyalgia pain factory?	34
Gender differences in patient journey to diagnosis and disease outcomes: results from the European Map of Axial Spondyloarthritis (EMAS)	34
Pneumocystis jirovecii pneumonia in autoimmune rheumatic diseases: a nationwide population-based study	33
Anti-melanoma differentiation-associated gene 5 (MDA5) antibody-positive dermatomyositis responds to rituximab therapy	32
Mendelian randomization study on the causal effects of omega-3 fatty acids on rheumatoid arthritis	31
Mechanisms of thrombosis in ANCA-associated vasculitis	29
Risk of venous thromboembolism associated with Janus kinase inhibitors for rheumatoid arthritis: case presentation and literature review	29

Idiopathic pulmonary hemosiderosis: a review of the treatments used during the past 30 years and future directions	28
Reactive arthritis before and after the onset of the COVID-19 pandemic	28
A practical approach for vaccinations including COVID-19 in autoimmune/autoinflammatory rheumatic diseases: a non-systematic review	27
Multisystem inflammatory syndrome in children during the COVID-19 pandemic in Turkey: first report from the Eastern Mediterranean	27
Burden of illness associated with eosinophilic granulomatosis with polyangiitis: a systematic literature review and meta-analysis	26
Threats to scholarly research integrity arising from paper mills: a rapid scoping review	26
Psoriatic arthritis and physical activity: a systematic review	26
Efficacy and safety of rituximab therapy in patients with systemic sclerosis disease (SSc): systematic review and meta-analysis	25
Plasma miRNAs improve the prediction of coronary atherosclerosis in patients with rheumatoid arthritis	24
Prevention of kidney function decline using uric acid-lowering therapy in chronic kidney disease patients: a systematic review and network meta-analysis	24
Anti-phospholipids antibodies and immune complexes in COVID-19 patients: a putative role in disease course for anti-annexin-V antibodies	24
Current status of the rheumatologists’ workforce in Latin America: a PANLAR collaborative study	24
Systemic lupus erythematosus in the light of the COVID-19 pandemic: infection, vaccination, and impact on disease management	23
Abatacept in rheumatoid arthritis-associated interstitial lung disease: short-term outcomes and predictors of progression	23
Janus kinase inhibitors and major COVID-19 outcomes: time to forget the two faces of Janus! A meta-analysis of randomized controlled trials	23
Serum anti-citrullinated protein antibodies and rheumatoid factor increase the risk of rheumatoid arthritis–related interstitial lung disease: a meta-analysis	23
Serum Krebs von den Lungen-6 and lung ultrasound B lines as potential diagnostic and prognostic factors for rheumatoid arthritis–associated interstitial lung disease	23
A review of applications of metabolomics in osteoarthritis	23
Systemic lupus erythematosus with acute pancreatitis and vasculitic rash following COVID-19 vaccine: a case report and literature review	23
Effect of nintedanib in patients with progressive pulmonary fibrosis associated with rheumatoid arthritis: data from the INBUILD trial	22
Ability and willingness to utilize telemedicine among rheumatology patients—a cross-sectional survey	22
Effect of JAK inhibitors on high- and low-density lipoprotein in patients with rheumatoid arthritis: a systematic review and network meta-analysis	22
Maternal and fetal outcomes in pregnant women with rheumatoid arthritis: a systematic review and meta-analysis	22
Educational quality of YouTube videos on musculoskeletal ultrasound	22
A systematic review of clinical and preclinical evidences for Janus kinase inhibitors in large vessel vasculitis	22
Systemic inflammatory response index as an independent risk factor for ischemic stroke in patients with rheumatoid arthritis: a retrospective study based on propensity score matching	21
Effects of resistance training on the mental health of patients with fibromyalgia: a systematic review	21
The quality of physiotherapy and rehabilitation program and the effect of telerehabilitation on patients with knee osteoarthritis	21
B cells in systemic sclerosis: from pathophysiology to treatment	20
Th17.1 lymphocytes: emerging players in the orchestra of immune-mediated inflammatory diseases	20
Comparing symptoms, treatment patterns, and quality of life of ankylosing spondylitis and non-radiographic axial spondyloarthritis patients in the USA: findings from a patient and rheumatologist Surve	19
Predictive factors for switching in patients with psoriatic arthritis undergoing anti-TNFα, anti-IL12/23, or anti-IL17 drugs: a 15-year monocentric real-life study	19
Rheumatoid arthritis-related interstitial lung disease (RA-ILD): a possible association between disease activity and prognosis	19
Comparative efficacy of amitriptyline, duloxetine and pregabalin for treating fibromyalgia in adults: an overview with network meta-analysis	19
New-onset Adult-onset Still’s disease-like syndrome after ChAdOx1 nCoV-19 vaccination—a case series with review of literature	19
Hip involvement in children with enthesitis related arthritis (ERA) is associated with poor outcomes in adulthood	18
Health disparities in systemic lupus erythematosus—a narrative review	18
The role of extracellular vesicles in rheumatoid arthritis: a systematic review	18
Clinical course and outcomes of COVID-19 in rheumatic disease patients: a case cohort study with a diverse population	18
Prospective correlational time-series analysis of the influence of weather and air pollution on joint pain in chronic rheumatic diseases	18
Prevalence and predictors of small intestinal bacterial overgrowth in systemic sclerosis: a systematic review and meta-analysis	18
Prevalence of liver fibrosis by Fibroscan in patients on long-term methotrexate therapy for rheumatoid arthritis	18
Alternative complement pathway activation in thrombotic microangiopathy associated with lupus nephritis	17
A bibliometric analysis of rheumatology and COVID-19 researches	17
Pregnancy outcomes in women with ankylosing spondylitis: a scoping literature and methodological review	17
Prevalence and risk of COVID-19 in patients with rheumatic diseases: a systematic review and meta-analysis	17
New-onset giant cell arteritis following COVID-19 mRNA (BioNTech/Pfizer) vaccine: a double-edged sword?	17
Use of ultrasound to diagnose and monitor interstitial lung disease in rheumatic diseases	17
Is there a potential dual effect of denosumab for treatment of osteoporosis and sarcopenia?	16
Biomarkers in axial spondyloarthritis and low back pain: a comprehensive review	16

How do patients define Raynaud’s phenomenon? Differences between primary and secondary disease	16
Are antiphospholipid antibodies just a common epiphenomenon or are they causative of immune-mediated coagulopathy in COVID-19?	16
Centralized nociplastic pain causing fibromyalgia: an emperor with no cloths?	16
Metabolic syndrome and adipokine levels in systemic lupus erythematosus and systemic sclerosis	16
The association between dietary inflammation index and the risk of rheumatoid arthritis in Americans	16
Incidence and risk factors of venous thromboembolism in ANCA-associated vasculitis: a metaanalysis and metaregression	16
A 4-week comparison of capillaroscopy changes, healing effect, and cost-effectiveness of botulinum toxin-A vs prostaglandin analog infusion in refractory digital ulcers in systemic sclerosis	16
Imbalance of Th17, Treg, and helper innate lymphoid cell in the peripheral blood of patients with rheumatoid arthritis	16
Enhanced echo intensity and a higher extracellular water-to-intracellular water ratio are helpful clinical signs for detecting muscle degeneration in patients with knee osteoarthritis	16
Serum interleukin-23 levels: relation to depression, anxiety, and disease activity in psoriatic arthritis patients	16
Estimation of the global prevalence, incidence, years lived with disability of rheumatoid arthritis in 2019 and forecasted incidence in 2040: results from the Global Burden of Disease Study 2019	16
Impact of COVID-19 on rheumatology practice in the UK—a pan-regional rheumatology survey	16
Clinical and ultrasound response to intralesional sodium thiosulfate for the treatment of calcinosis cutis in the setting of systemic sclerosis. A case-based review	15
Drug retention of sarilumab, baricitinib, and tofacitinib in patients with rheumatoid arthritis: the ANSWER cohort study	15
Functional manifestations of early knee osteoarthritis: a systematic review and meta-analysis	15
The impact of gender and sex on diagnosis, treatment outcomes and health-related quality of life in patients with axial spondyloarthritis	15
Efficacy and safety of interleukin-17A inhibitors in patients with ankylosing spondylitis: a systematic review and meta-analysis of randomized controlled trials	15
Dysregulated microRNA expression in rheumatoid arthritis families—a comparison between rheumatoid arthritis patients, their first-degree relatives, and healthy controls	15
Incidence of autoimmune diseases in people living with HIV compared to a matched population: a cohort study	15
Work absenteeism and disability associated with psoriasis and psoriatic arthritis in the USA—a retrospective study of claims data from 2009 TO 2020	15
Lupus animal models and neuropsychiatric implications	14
Risk factors for progression of interstitial lung disease in Sjögren’s syndrome: a single-centered, retrospective study	14
A clinical model for predicting knee replacement in early-stage knee osteoarthritis: data from osteoarthritis initiative	14
Prevalence and clinical associations with premature ovarian insufficiency, early menopause, and low ovarian reserve in systemic sclerosis	14
Osteoporosis in patients with rheumatoid arthritis is associated with serum immune regulatory cellular factors	14
Efficacy of mycophenolate mofetil versus cyclophosphamide in systemic sclerosis-related interstitial lung disease: a systematic review and meta-analysis	14
Extracellular-to-intracellular water ratios are associated with functional disability levels in patients with knee osteoarthritis: results from the Nagahama Study	14
Utility of pulmonary ultrasound to identify interstitial lung disease in patients with rheumatoid arthritis	14
Prevalence and incidence of osteoarthritis among people living in the Gulf Cooperation Council countries: a systematic review and meta-analysis	14
Tumor necrosis factor inhibitors prevent structural damage in hips in ankylosing spondylitis—time to reconsider treatment guidelines? A case series and review of literature	14
Pulmonary hypertension in connective tissue diseases: epidemiology, pathogenesis, and treatment	14
Association of anti-NXP2 antibody with clinical characteristics and outcomes in adult dermatomyositis: results from clinical applications based on a myositis-specific antibody	13
Risk factors for septic arthritis and multiple arthroscopic washouts: minimum 2-year follow-up at a major trauma centre	13
PFAPA (periodic fever, aphthous stomatitis, pharyngitis, and adenitis) syndrome: an overview of genetic background	13
A narrative review of imaging in calcinosis associated with systemic sclerosis	13
Proteomics analysis of lysine crotonylation and 2-hydroxyisobutyrylation reveals significant features of systemic lupus erythematosus	13
Effects of melatonin supplementation on disease activity, oxidative stress, inflammatory, and metabolic parameters in patients with rheumatoid arthritis: a randomized double-blind placebo-controlled t	13
The trajectories of depression symptoms and comorbidity in knee osteoarthritis subjects	13
Three new inflammatory markers C reactive protein to albumin ratio, neutrophil to lymphocyte ratio, and platelet to lymphocyte ratio correlated with relapsing polychondritis disease activity index	13
Adverse events and disease flares after SARS-CoV-2 vaccination in patients with systemic lupus erythematosus	13
Antineutrophil cytoplasmic antibodies in infective endocarditis: a case report and systematic review of the literature	13
Antibody responses after documented COVID-19 disease in patients with autoimmune rheumatic disease	13
Many people admitted to hospital with a provisional diagnosis of nonserious back pain are subsequently found to have serious pathology as the underlying cause	13
Vacuoles, E1 enzyme, X-linked, autoinflammatory, somatic syndrome (VEXAS syndrome) with prominent supraglottic larynx involvement: a case-based review	13
Anti-mitochondrial autoantibodies are associated with cardiomyopathy, dysphagia, and features of more severe disease in adult-onset myositis	13
Lower education is an associated factor with the combination of pain catastrophizing and kinesiophobia in patients with knee osteoarthritis?	13
Predictors of remission in rheumatoid arthritis patients treated with biologics: a systematic review and meta-analysis	13
Risk of COVID-19 infection in patients with rheumatic disease taking disease-modifying anti-rheumatic drugs	13
Nailfold capillaroscopy: tips and challenges	13
Efficacy of interleukin-1 blockade in Schnitzler’s syndrome without detectable monoclonal gammopathy: a case-based review	13
Synovial biopsies in clinical practice and research: current developments and perspectives	13
Systemic lupus erythematous after Pfizer COVID-19 vaccine: a case report	13
Myocardial involvement in idiopathic inflammatory myopathies: a multi-center cross-sectional study in the CRDC-MYO Registry	13
Characterization of visual manifestations and identification of risk factors for permanent vision loss in patients with giant cell arteritis	12
Efficacy and safety of rituximab on lung and skin involvement in systemic sclerosis: a systematic review and metaanalysis	12
Mobile health technologies for the management of rheumatic diseases: a systematic review of online stores in Brazil	12
The impact of SARS-CoV-2 coronavirus infection in patients with systemic lupus erythematosus from a single center in Catalonia	12
Healthcare utilization and costs among patients with psoriasis and psoriatic arthritis in the USA–a retrospective study of claims data from 2009 to 2020	12
Gastrointestinal involvement in IgA vasculitis: a single-center 11-year study on a cohort of 118 children	12
Tumor markers are associated with rapidly progressive interstitial lung disease in adult-dermatomyositis	12
The untapped potential of Instagram to facilitate rheumatology academia	12
Investigating the relationship between the severity of periodontitis and rheumatoid arthritis: a cross-sectional study	12
Flare of adult-onset Still’s disease following mRNA COVID-19 vaccination: a case report and review of literature	12
Pulmonary vasculitis in Hughes-Stovin syndrome (HSS): a reference atlas and computed tomography pulmonary angiography guide—a report by the HSS International Study Group	12
Determinants and protective associations of the lupus low disease activity state in a prospective Chinese cohort	12
Lifestyle factors in patients with rheumatoid arthritis—a cross-sectional study on two Scandinavian cohorts	12
A critical review of the available evidence on the diagnosis and clinical features of CPPD: do we really need imaging?	12
Comparative transcriptomics and network pharmacology analysis to identify the potential mechanism of celastrol against osteoarthritis	12
Peripheral microcirculatory abnormalities are associated with cardiovascular risk in systemic sclerosis: a nailfold video capillaroscopy study	12
Dickkopf-1 perpetuated synovial fibroblast activation and synovial angiogenesis in rheumatoid arthritis	12
The role of dual energy computed tomography in the differentiation of acute gout flares and acute calcium pyrophosphate crystal arthritis	12
Prevalence of autoantibodies in pediatric patients with idiopathic pulmonary hemosiderosis: a scoping review of the literature in the period 1980–2021	12
Challenges of caring for homeless patients with rheumatic and musculoskeletal disorders in Los Angeles	12
Lung magnetic resonance imaging in systemic sclerosis: a new promising approach to evaluate pulmonary involvement and progression	12
Emergence of de novo cutaneous vasculitis post coronavirus disease (COVID-19) vaccination	11
Inflammatory arthritis-associated pyoderma gangrenosum: a systematic review	11
Comparison of the clinical diagnostic criteria and the results of the next-generation sequence gene panel in patients with monogenic systemic autoinflammatory diseases	11
Tripterygium wilfordii Hook F. in the treatment of synovitis, acne, pustulosis, hyperostosis, and osteitis syndrome: a clinical trial	11
Transcriptional expression of CXCL10 and STAT1 in lupus nephritis and the intervention effect of triptolide	11
Nociplastic pain concept, a mechanistic basis for pragmatic approach to fibromyalgia	11

Evaluation of serum interleukin-6 (IL-6), IL-13, and IL-17 levels and computed tomography finding in interstitial lung disease associated with connective tissue disease patients	11
Acute effect of green tea catechins on uric acid metabolism after alcohol ingestion in Japanese men	11
Cardiovascular issues in rheumatic diseases	11
Polycystic ovary syndrome and (pre)osteoarthritis: assessing the link between hyperandrogenism in young women and cartilage oligomeric matrix protein as a marker of cartilage breakdown	11
Rheumatologic diseases in patients with inborn errors of immunity in the USIDNET registry	11
Differentiation of idiopathic pulmonary hemosiderosis from rheumatologic and autoimmune diseases causing diffuse alveolar hemorrhage: establishing a diagnostic approach	11
Leukocytoclastic vasculitis after the third dose of CoronaVac vaccination	11
The positive side of the coin: Sars-Cov-2 pandemic has taught us how much Telemedicine is useful as standard of care procedure in real life	11
The expanded spectrum of arthritis in children with familial Mediterranean fever	11
A comprehensive overview of living with Sjögren’s: results of a National Sjögren’s Foundation survey	11
Bone mineral density, vitamin D receptor (VDR) gene polymorphisms, fracture risk assessment (FRAX), and trabecular bone score (TBS) in rheumatoid arthritis patients: connecting pieces of the puzzle	11
Prognostic factors in IgG4-related disease: a long-term monocentric Chinese cohort study	11
Disease activity indices in psoriatic arthritis: current and evolving concepts	11
Validity of systemic lupus erythematosus disease activity score (SLE-DAS) for definition of lupus low disease activity state (LLDAS)	11
Factors that influence biological survival in rheumatoid arthritis: results of a real-world academic cohort from the Netherlands	11
Factors associated with COVID-19 and its outcome in patients with rheumatoid arthritis	11
Clinical phenotype and cytokine profile of adult IgA vasculitis with joint involvement	11
Outcomes of achieving lupus low disease activity state and damage accrual in childhood-onset systemic lupus erythematosus	11
Janus kinase (JAK) inhibitors significantly reduce the humoral vaccination response against SARS-CoV-2 in patients with rheumatoid arthritis	11
A historical journey of searching for uricosuric drugs	11
Characteristics and phenotype heterogeneity in late-onset Behçet’s syndrome: a cohort from a referral center in China	11
Glucocorticoid therapy suppresses Wnt signaling by reducing the ratio of serum Wnt3a to Wnt inhibitors, sFRP-1 and Wif-1	11
A systematic review and meta-analysis of the hyperuricemia risk from certain metals	11
Assessment of quality and reliability of YouTube videos for patient and physician education on inflammatory myositis	11
COVID-19, rheumatic diseases and immune dysregulation—a perspective	10
Cardiovascular risks associated with Janus kinase inhibitors: peering outside the black box	10
Factors affecting quality of life in patients with rheumatoid arthritis in South Korea: a cross-sectional study	10
Effects of biologic and target synthetic disease-modifying anti-rheumatic drugs on sarcopenia in spondyloarthritis and rheumatoid arthritis: a systematic review and meta-analysis	10
Presentation and clinical course of pediatric-onset versus adult-onset Takayasu arteritis—a systematic review and meta-analysis	10
Gender influence on clinical manifestations, depressive symptoms and brain-derived neurotrophic factor (BDNF) serum levels in patients affected by fibromyalgia	10
Validation of two simple patient-centered outcome measures for virtual monitoring of patients with idiopathic inflammatory myositis	10
Physicians’ perceptions about antineutrophil cytoplasmic antibody-associated vasculitis: an online survey report in the time of the COVID-19 pandemic	10
Cardiovascular risk in axial spondyloarthritis—a systematic review	10
Can we finally exonerate methotrexate as a factor in causing or exacerbating fibrotic interstitial lung disease in patients with rheumatoid arthritis?	10
Retention of subcutaneous abatacept for the treatment of rheumatoid arthritis: real-world results from the ASCORE study: an international 2-year observational study	10
Real-world evaluation of effectiveness, persistence, and usage patterns of monotherapy and combination therapy tofacitinib in treatment of rheumatoid arthritis in Australia	10
Survival and outcomes after lung transplantation for connective tissue disease-associated interstitial lung diseases	10
Dyslipidemia is associated with inflammation and organ involvement in systemic lupus erythematosus	10
Asymptomatic SARS-CoV-2 seropositivity: patients with childhood-onset rheumatic diseases versus healthy children	10
Characteristics of immune function in the acute phase of Henoch-Schönlein purpura	10
Myositis-specific antibodies and clinical characteristics in patients with autoimmune inflammatory myopathies: reported by the Argentine Registry of Inflammatory Myopathies of the Argentine Society of	10
Risk factors for primary Sjögren’s Syndrome: a systematic review and meta-analysis	10
Sociodemographic and clinical factors associated with poor COVID-19 outcomes in patients with rheumatic diseases: data from the SAR-COVID Registry	10
Kawasaki disease and influenza—new lessons from old associations	10
Genotype–phenotype associations in familial Mediterranean fever: a study of 500 Egyptian pediatric patients	10
Sonographic evaluation of the association between calcific tendinopathy and rotator cuff tear: a case-controlled comparison	10
Management of mixed cryoglobulinemia with rituximab: evidence and consensus-based recommendations from the Italian Study Group of Cryoglobulinemia (GISC)	10
Management of psoriatic arthritis in rheumatology and dermatology settings: sub-analysis of the Italian population from the international LOOP study	10
New-onset systemic vasculitis following SARS-CoV-2 infection and vaccination: the trigger, phenotype, and outcome	10
Prevalence of pediatric Kashin-Beck disease in Tibet	10
Polycystic ovary syndrome: epidemiologic assessment of prevalence of systemic rheumatic and autoimmune diseases	10
Analysis of the clinical features of antisynthetase syndrome: a retrospective cohort study in China	10
Tofacitinib for new-onset adult patients with anti-melanoma differentiation-associated 5 gene antibody positive dermatomyositis	10
Clinical outcomes of COVID-19 patients with rheumatic diseases: a retrospective cohort study and synthesis analysis in Wuhan, China	9
High serum IgA and activated Th17 and Treg predict the efficacy of abatacept in patients with early, seropositive rheumatoid arthritis	9
Coronavirus disease 2019 in patients with Behcet’s disease: a report of 59 cases in Iran	9
Two flares of Still’s disease after two doses of the ChAdOx1 vaccine	9
Colchicine may become a new cornerstone therapy for coronary artery disease: a meta‐analysis of randomized controlled trials	9
Inflammatory markers and risk factors of RA patients with depression and application of different scales in judging depression	9
Identification of differential key biomarkers in the synovial tissue between rheumatoid arthritis and osteoarthritis using bioinformatics analysis	9
Earlier chronotype in patients with rheumatoid arthritis	9
Adalimumab-induced sarcoidosis-like reaction involving oral cavity in rheumatoid arthritis: a case-based review	9
The relationship between COVID-19 and fibromyalgia syndrome: prevalence, pandemic effects, symptom mechanisms, and COVID-19 vaccines	9
Short-term, low-dose etoposide in refractory adult-onset Still’s disease-associated macrophage activation syndrome	9
Efficacy and safety of weekly vitamin D3 in patients with fibromyalgia: 12-week, double-blind, randomized, controlled placebo trial	9
Diagnostic validity of ultrasound including extra-cranial arteries in giant cell arteritis	9
Factors associated with frailty in Japanese patients with rheumatoid arthritis: results from the Institute of Rheumatology Rheumatoid Arthritis cohort study	9
Clinical spectrum and therapeutic management of systemic lupus erythematosus-associated macrophage activation syndrome: a study of 20 Moroccan adult patients	9
Linking physical activity with clinical, functional, and structural outcomes: an evidence map using the Osteoarthritis Initiative	9
The effectiveness of tocilizumab in treating refractory adult-onset Still’s disease with dichotomous phenotypes: IL-18 is a potential predictor of therapeutic response	9
Computed tomography pulmonary angiography (CTPA) in Behçet’s disease patients: a remarkable gender gap and time to refine the treatment strategy	9
Myositis-specific autoantibodies and their clinical associations in idiopathic inflammatory myopathies: results from a cohort from China	9
Anti-vinculin antibodies in scleroderma (SSc): a potential link between autoimmunity and gastrointestinal system involvement in two SSc cohorts	9
Prevalence and risk factors of herpes zoster infection in patients with rheumatic diseases not receiving biologic or targeted therapies	9
Rheumatoid arthritis and myasthenia gravis: a case-based review of the therapeutic options	9
Juvenile Behçet’s disease: a tertiary center experience	9
Interleukin-35 promotes Breg expansion and interleukin-10 production in CD19+ B cells in patients with ankylosing spondylitis	9
Coexistence of fibromyalgia syndrome and inflammatory rheumatic diseases, and autonomic cardiovascular system involvement in fibromyalgia syndrome	9
Factors associated with long-term retention of treatment with golimumab in rheumatoid arthritis, axial spondyloarthritis, and psoriatic arthritis: an analysis of the Spanish BIOBADASER registry	9
Whole genome sequencing identifies variants associated with sarcoidosis in a family with a high prevalence of sarcoidosis	9
Adult-onset deficiency of adenosine deaminase 2—a case report and literature review	9
What are the core recommendations for rheumatoid arthritis care? Systematic review of clinical practice guidelines	9
Psoriatic arthritis with hyperuricemia: more peripheral, destructive, and challenging to treat	9
Comorbidities and factors influencing frequent gout attacks in patients with gout: a cross-sectional study	9
Chagas disease reactivation in rheumatologic patients: association with immunosuppressive therapy and humoral response	9
Performance of the EULAR/ACR 2019 classification criteria for systemic lupus erythematous in monogenic lupus	9
Systemic syndromes of rheumatological interest with onset after COVID-19 vaccine administration: a report of 30 cases	9
Association between biopsies for anti-neutrophil cytoplasmic antibody-associated vasculitis and prognosis: a retrospective cohort study	9
Imaging features of 18F-FDG PET/CT in different types of systemic vasculitis	9
Axial spondyloarthritis may protect against poor outcomes in COVID-19: propensity score matched analysis of 9766 patients from a nationwide multi-centric research network	9
Entheseal involvement of the lower extremities in gout: an ultrasonographic descriptive observational study	9
Pediatric inflammatory multisystem syndrome (PIMS) presenting with retropharyngeal phlegmon mimicking Kawasaki disease	9
An Argentinean cohort of patients with rheumatic and immune-mediated diseases vaccinated for SARS-CoV-2: the SAR-CoVAC Registry—protocol and preliminary data	9
Prediction of progressive pulmonary fibrosis in patients with anti-synthetase syndrome-associated interstitial lung disease	9
Hydroxychloroquine blood levels in stable lupus nephritis under low dose (2–3 mg/kg/day): 12-month prospective randomized controlled trial	9